Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Carter

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
New York State Journal of Medicine|April 1, 1975
Cytomegalovirus infection with acute myelocytic leukemia; antiviral (interferon and antibody) responsesJ A O'Malley, N al-Bussam, K Beutner, et al.
Annals of the New York Academy of Sciences|June 23, 1993
Specific RNA drug therapy of hepatitis virusesW A Carter, R J Suhadolnik, W E Müller, et al.
Journal of Biological Response Modifiers|October 1, 1987
Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograftH R Hubbell, E C Pequignot, J Todd, et al.
Cancer Letters|September 1, 1979
Purified human fibroblast interferon in vivo: skin reactions and effect on bone marrow precursor cellsW A Carter, J G Dolen, S S Leong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1994
A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndromeD R Strayer, W A Carter, I Brodsky, et al.
Cancer Treatment Reports|November 1, 1978
Human fibroblast interferon in human neoplasia: clinical and laboratory studyJ S Horoszewicz, S S Leong, M Ito, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograftH R Hubbell, H E Vargas, K L Tsujimoto, et al.
Molecular Pharmacology|January 1, 1975
Antiviral activity of partially thiolated polynucleotidesJ A O'Malley, Y K Ho, P Chakrabarti, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1996
Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infectionK A Thompson, D R Strayer, P D Salvato, et al.
International Journal of Cancer|December 15, 1974
Inhibition by streptovaricins of Rauscher leukemia virus splenomegalyE C Borden, W A Carter, L L Sensenbrenner, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
New York State Journal of Medicine|April 1, 1975
Cytomegalovirus infection with acute myelocytic leukemia; antiviral (interferon and antibody) responsesJ A O'Malley, N al-Bussam, K Beutner, et al.
Annals of the New York Academy of Sciences|June 23, 1993
Specific RNA drug therapy of hepatitis virusesW A Carter, R J Suhadolnik, W E Müller, et al.
Journal of Biological Response Modifiers|October 1, 1987
Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograftH R Hubbell, E C Pequignot, J Todd, et al.
Cancer Letters|September 1, 1979
Purified human fibroblast interferon in vivo: skin reactions and effect on bone marrow precursor cellsW A Carter, J G Dolen, S S Leong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1994
A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndromeD R Strayer, W A Carter, I Brodsky, et al.
Cancer Treatment Reports|November 1, 1978
Human fibroblast interferon in human neoplasia: clinical and laboratory studyJ S Horoszewicz, S S Leong, M Ito, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograftH R Hubbell, H E Vargas, K L Tsujimoto, et al.
Molecular Pharmacology|January 1, 1975
Antiviral activity of partially thiolated polynucleotidesJ A O'Malley, Y K Ho, P Chakrabarti, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1996
Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infectionK A Thompson, D R Strayer, P D Salvato, et al.
International Journal of Cancer|December 15, 1974
Inhibition by streptovaricins of Rauscher leukemia virus splenomegalyE C Borden, W A Carter, L L Sensenbrenner, et al.
Pageof 13